Su Victoria相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Are Canadian Clinical Practice Guidelines Accounting for Adults With Multiple Chronic Diseases? A Systematic Review

加拿大临床实践指南是否考虑到了患有多种慢性疾病的成年人？一项系统性综述

期刊:Journal of Evaluation in Clinical Practice

影响因子:2.1

doi:10.1111/jep.70143

Tseng, Olivia L; Brar, Shanjot; Dawes, Martin; Ranchod, Hetesh; Lacaille, Diane; Su, Victoria C H; Mitton, Craig

发表日期：2025

文献求助收藏

Optimal Therapeutic Drug Monitoring Strategy for IV Aminoglycosides and IV Vancomycin in People with Cystic Fibrosis: A Systematic Review

囊性纤维化患者静脉注射氨基糖苷类和万古霉素的最佳治疗药物监测策略：系统评价

doi:10.4212/cjhp.3429

Jiang, Jessie; Giunio-Zorkin, Nicole; Su, Victoria; Dagenais, Renée

发表日期：2023

文献求助收藏

Endothelial pannexin-1 channels modulate macrophage and smooth muscle cell activation in abdominal aortic aneurysm formation

内皮 pannexin-1 通道调节腹主动脉瘤形成过程中的巨噬细胞和平滑肌细胞活化

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-022-29233-4

Amanda C Filiberto, Michael D Spinosa, Craig T Elder, Gang Su, Victoria Leroy, Zachary Ladd, Guanyi Lu, J Hunter Mehaffey, Morgan D Salmon, Robert B Hawkins, Kodi S Ravichandran, Brant E Isakson, Gilbert R Upchurch Jr, Ashish K Sharma

细胞生物学

发表日期：2022

文献求助收藏

Correction: Dagenais et al. Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review. J. Clin. Med. 2021, 10, 23

更正：Dagenais 等人，《囊性纤维化治疗中 CFTR 调节剂的真实世界安全性：系统评价》，《临床医学杂志》，2021 年，10 月，23 页。

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm11020318

Dagenais, Renée V E; Su, Victoria C; Quon, Bradley S

发表日期：2022

文献求助收藏

Evaluating a Pharmacist-Led Opioid Stewardship Initiative at an Urban Teaching Hospital

评估一家城市教学医院由药剂师主导的阿片类药物管理计划

doi:10.4212/cjhp.v74i3.3152

Chen, Anna; Legal, Michael; Shalansky, Stephen; Mihic, Tamara; Su, Victoria

发表日期：2021

文献求助收藏

Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review

囊性纤维化治疗中CFTR调节剂的真实世界安全性：系统评价

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm10010023

Dagenais, Renée V E; Su, Victoria C H; Quon, Bradley S

发表日期：2020

文献求助收藏

Impact of PharmaNet-Based Admission Medication Reconciliation on Best Possible Medication Histories for Warfarin

基于 PharmaNet 的入院用药核对对华法林最佳用药史的影响

doi:10.4212/cjhp.v69i5.1589

Au, Debbie; Wu, Hilary; San, Cindy; Chua, Doson; Su, Victoria; Kirkwood, Allison

发表日期：2016

文献求助收藏

Characterization of Venous Thromboembolism Risk in Medical Inpatients Using Different Clinical Risk Assessment Models

利用不同临床风险评估模型对住院患者静脉血栓栓塞风险进行特征分析

doi:10.4212/cjhp.v69i6.1608

Rafizadeh, Reza; Turgeon, Ricky D; Batterink, Josh; Su, Victoria; Lau, Anthony

发表日期：2016

文献求助收藏

Approach to the pharmacological management of chronic pain in patients with an alcohol use disorder

酒精使用障碍患者慢性疼痛的药物治疗方法

期刊:Journal of Pain Research

影响因子:2.5

doi:10.2147/JPR.S88900

Murphy, Laura; Ng, Karen Wk; Su, Victoria Ch; Woodworth-Giroux, Sarah; Levy, Todd S; Sproule, Beth A; Furlan, Andrea D

发表日期：2015

文献求助收藏

RIOK3 is an adaptor protein required for IRF3-mediated antiviral type I interferon production.

RIOK3 是一种衔接蛋白，是 IRF3 介导的抗病毒 I 型干扰素产生所必需的

期刊:Journal of Virology

影响因子:3.8

doi:10.1128/JVI.00643-14

Feng Jun, De Jesus Paul D, Su Victoria, Han Stephanie, Gong Danyang, Wu Nicholas C, Tian Yuan, Li Xudong, Wu Ting-Ting, Chanda Sumit K, Sun Ren

免疫/内分泌

发表日期：2014

文献求助收藏